We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




30 Million Children Vaccinated by Global Agencies

By Biotechdaily staff writers
Posted on 30 Jul 2003
Five-year commitments to immunize children in the world's poorest countries have exceeded US$1 billion, according to the Global Alliance for Vaccines and Immunization (GAVI, Washington, DC, USA). More...
Already, 30 million children have benefited from the nearly $250 million in new vaccines and infrastructure disbursed so far.

Including Angola, Chad, and Congo, which were recently approved for funding, 71 countries have received vaccines from The Vaccine Fund, the financing arm of GAVI. Many of these are showing impressive signs of success. Immunization rates in Mali and Uganda, for example, have reversed their falling coverage rate of the late 1990s and are now reaching even more children than they had anticipated in their original application. The agencies estimate that global immunization efforts will prevent as many as 300,000 deaths. Two out of every three nonimmunized children are in five countries: India, Nigeria, China, Pakistan, and Indonesia.

GAVI was created as a public/private partnership to reverse the decline in immunization coverage in developing countries during the 1990s and was launched with an initial grant from the Bill & Melinda Gates Foundation. Other participants include national governments, UNICEF, WHO, The World Bank, the vaccine industry, and public health organizations.

"As new vaccines become available and more children are born in developing countries, costs are soaring for The Vaccine Fund,” said Jacques-Francois Martin, president. "We urgently need to raise more money and bring new public and private donors to the table.”




Related Links:
Global Alliance for Vaccines and Immunization

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
All-in-One Molecular System
AIO M160
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.